nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibandronate—FDPS—Sorafenib—Vismodegib—skin cancer	0.0287	1	CbGdCrCtD
Ibandronate—FDPS—hair follicle—skin cancer	0.0195	0.24	CbGeAlD
Ibandronate—FDPS—nipple—skin cancer	0.0133	0.163	CbGeAlD
Ibandronate—FDPS—connective tissue—skin cancer	0.0094	0.116	CbGeAlD
Ibandronate—FDPS—skin of body—skin cancer	0.00849	0.104	CbGeAlD
Ibandronate—FDPS—mammalian vulva—skin cancer	0.00774	0.0952	CbGeAlD
Ibandronate—FDPS—lymphoid tissue—skin cancer	0.00687	0.0845	CbGeAlD
Ibandronate—FDPS—female reproductive system—skin cancer	0.00663	0.0815	CbGeAlD
Ibandronate—FDPS—head—skin cancer	0.00554	0.0681	CbGeAlD
Ibandronate—Risedronate—PTGS2—skin cancer	0.00525	1	CrCbGaD
Ibandronate—FDPS—lymph node—skin cancer	0.00388	0.0477	CbGeAlD
Ibandronate—Upper respiratory tract infection—Fluorouracil—skin cancer	0.00139	0.00157	CcSEcCtD
Ibandronate—Paraesthesia—Imiquimod—skin cancer	0.00139	0.00157	CcSEcCtD
Ibandronate—Chills—Bleomycin—skin cancer	0.00139	0.00157	CcSEcCtD
Ibandronate—Hepatobiliary disease—Temozolomide—skin cancer	0.00137	0.00155	CcSEcCtD
Ibandronate—Alopecia—Bleomycin—skin cancer	0.00136	0.00154	CcSEcCtD
Ibandronate—Dyspepsia—Imiquimod—skin cancer	0.00136	0.00154	CcSEcCtD
Ibandronate—Pneumonia—Fluorouracil—skin cancer	0.00134	0.00152	CcSEcCtD
Ibandronate—Erythema—Bleomycin—skin cancer	0.00134	0.00152	CcSEcCtD
Ibandronate—Decreased appetite—Imiquimod—skin cancer	0.00134	0.00152	CcSEcCtD
Ibandronate—Infestation NOS—Fluorouracil—skin cancer	0.00134	0.00151	CcSEcCtD
Ibandronate—Infestation—Fluorouracil—skin cancer	0.00134	0.00151	CcSEcCtD
Ibandronate—Hypersensitivity—Vemurafenib—skin cancer	0.00133	0.00151	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Imiquimod—skin cancer	0.00133	0.00151	CcSEcCtD
Ibandronate—Fatigue—Imiquimod—skin cancer	0.00133	0.0015	CcSEcCtD
Ibandronate—Pain—Imiquimod—skin cancer	0.00132	0.00149	CcSEcCtD
Ibandronate—Renal impairment—Docetaxel—skin cancer	0.00132	0.00149	CcSEcCtD
Ibandronate—Haemoglobin—Temozolomide—skin cancer	0.00131	0.00148	CcSEcCtD
Ibandronate—Stomatitis—Fluorouracil—skin cancer	0.0013	0.00147	CcSEcCtD
Ibandronate—Haemorrhage—Temozolomide—skin cancer	0.0013	0.00147	CcSEcCtD
Ibandronate—Urinary tract infection—Fluorouracil—skin cancer	0.0013	0.00147	CcSEcCtD
Ibandronate—Asthenia—Vemurafenib—skin cancer	0.0013	0.00147	CcSEcCtD
Ibandronate—Pharyngitis—Temozolomide—skin cancer	0.00129	0.00146	CcSEcCtD
Ibandronate—Chills—Dactinomycin—skin cancer	0.00129	0.00146	CcSEcCtD
Ibandronate—Urinary tract disorder—Temozolomide—skin cancer	0.00129	0.00145	CcSEcCtD
Ibandronate—Oedema peripheral—Temozolomide—skin cancer	0.00128	0.00145	CcSEcCtD
Ibandronate—Pruritus—Vemurafenib—skin cancer	0.00128	0.00145	CcSEcCtD
Ibandronate—Connective tissue disorder—Temozolomide—skin cancer	0.00128	0.00145	CcSEcCtD
Ibandronate—Urethral disorder—Temozolomide—skin cancer	0.00128	0.00144	CcSEcCtD
Ibandronate—Alopecia—Dactinomycin—skin cancer	0.00127	0.00144	CcSEcCtD
Ibandronate—Feeling abnormal—Imiquimod—skin cancer	0.00127	0.00144	CcSEcCtD
Ibandronate—Gastrointestinal pain—Imiquimod—skin cancer	0.00126	0.00143	CcSEcCtD
Ibandronate—Erythema—Dactinomycin—skin cancer	0.00125	0.00142	CcSEcCtD
Ibandronate—Pain in extremity—Docetaxel—skin cancer	0.00125	0.00141	CcSEcCtD
Ibandronate—Ill-defined disorder—Bleomycin—skin cancer	0.00125	0.00141	CcSEcCtD
Ibandronate—Anaemia—Bleomycin—skin cancer	0.00124	0.0014	CcSEcCtD
Ibandronate—Diarrhoea—Vemurafenib—skin cancer	0.00124	0.0014	CcSEcCtD
Ibandronate—Migraine—Docetaxel—skin cancer	0.00123	0.00139	CcSEcCtD
Ibandronate—Urticaria—Imiquimod—skin cancer	0.00123	0.00139	CcSEcCtD
Ibandronate—Abdominal pain—Imiquimod—skin cancer	0.00122	0.00138	CcSEcCtD
Ibandronate—Body temperature increased—Imiquimod—skin cancer	0.00122	0.00138	CcSEcCtD
Ibandronate—Eye disorder—Temozolomide—skin cancer	0.00122	0.00138	CcSEcCtD
Ibandronate—Malaise—Bleomycin—skin cancer	0.00121	0.00137	CcSEcCtD
Ibandronate—Cardiac disorder—Temozolomide—skin cancer	0.00121	0.00137	CcSEcCtD
Ibandronate—Haemoglobin—Fluorouracil—skin cancer	0.00121	0.00136	CcSEcCtD
Ibandronate—Haemorrhage—Fluorouracil—skin cancer	0.0012	0.00136	CcSEcCtD
Ibandronate—Dizziness—Vemurafenib—skin cancer	0.0012	0.00135	CcSEcCtD
Ibandronate—Pharyngitis—Fluorouracil—skin cancer	0.00119	0.00135	CcSEcCtD
Ibandronate—Angiopathy—Temozolomide—skin cancer	0.00118	0.00134	CcSEcCtD
Ibandronate—Immune system disorder—Temozolomide—skin cancer	0.00118	0.00133	CcSEcCtD
Ibandronate—Mediastinal disorder—Temozolomide—skin cancer	0.00117	0.00133	CcSEcCtD
Ibandronate—Chills—Temozolomide—skin cancer	0.00117	0.00132	CcSEcCtD
Ibandronate—Ill-defined disorder—Dactinomycin—skin cancer	0.00116	0.00131	CcSEcCtD
Ibandronate—Anaemia—Dactinomycin—skin cancer	0.00116	0.00131	CcSEcCtD
Ibandronate—Vomiting—Vemurafenib—skin cancer	0.00115	0.0013	CcSEcCtD
Ibandronate—Alopecia—Temozolomide—skin cancer	0.00115	0.0013	CcSEcCtD
Ibandronate—Chest pain—Bleomycin—skin cancer	0.00114	0.00129	CcSEcCtD
Ibandronate—Myalgia—Bleomycin—skin cancer	0.00114	0.00129	CcSEcCtD
Ibandronate—Abdominal pain upper—Docetaxel—skin cancer	0.00114	0.00129	CcSEcCtD
Ibandronate—Rash—Vemurafenib—skin cancer	0.00114	0.00129	CcSEcCtD
Ibandronate—Mental disorder—Temozolomide—skin cancer	0.00114	0.00129	CcSEcCtD
Ibandronate—Dermatitis—Vemurafenib—skin cancer	0.00114	0.00129	CcSEcCtD
Ibandronate—Hypersensitivity—Imiquimod—skin cancer	0.00114	0.00129	CcSEcCtD
Ibandronate—Headache—Vemurafenib—skin cancer	0.00113	0.00128	CcSEcCtD
Ibandronate—Malnutrition—Temozolomide—skin cancer	0.00113	0.00128	CcSEcCtD
Ibandronate—Erythema—Temozolomide—skin cancer	0.00113	0.00128	CcSEcCtD
Ibandronate—Breast disorder—Docetaxel—skin cancer	0.00113	0.00128	CcSEcCtD
Ibandronate—Discomfort—Bleomycin—skin cancer	0.00113	0.00128	CcSEcCtD
Ibandronate—Malaise—Dactinomycin—skin cancer	0.00113	0.00128	CcSEcCtD
Ibandronate—Cramp muscle—Docetaxel—skin cancer	0.00113	0.00127	CcSEcCtD
Ibandronate—Nasopharyngitis—Docetaxel—skin cancer	0.00112	0.00127	CcSEcCtD
Ibandronate—Dysgeusia—Temozolomide—skin cancer	0.00111	0.00125	CcSEcCtD
Ibandronate—Asthenia—Imiquimod—skin cancer	0.00111	0.00125	CcSEcCtD
Ibandronate—Anaphylactic shock—Bleomycin—skin cancer	0.0011	0.00124	CcSEcCtD
Ibandronate—Back pain—Temozolomide—skin cancer	0.0011	0.00124	CcSEcCtD
Ibandronate—Pruritus—Imiquimod—skin cancer	0.00109	0.00123	CcSEcCtD
Ibandronate—Infection—Bleomycin—skin cancer	0.00109	0.00123	CcSEcCtD
Ibandronate—Dysphagia—Docetaxel—skin cancer	0.00108	0.00122	CcSEcCtD
Ibandronate—Nausea—Vemurafenib—skin cancer	0.00108	0.00122	CcSEcCtD
Ibandronate—Myalgia—Dactinomycin—skin cancer	0.00107	0.00121	CcSEcCtD
Ibandronate—Bronchospasm—Docetaxel—skin cancer	0.00106	0.0012	CcSEcCtD
Ibandronate—Alopecia—Fluorouracil—skin cancer	0.00106	0.0012	CcSEcCtD
Ibandronate—Diarrhoea—Imiquimod—skin cancer	0.00106	0.00119	CcSEcCtD
Ibandronate—Discomfort—Dactinomycin—skin cancer	0.00105	0.00119	CcSEcCtD
Ibandronate—Ill-defined disorder—Temozolomide—skin cancer	0.00105	0.00119	CcSEcCtD
Ibandronate—Anaemia—Temozolomide—skin cancer	0.00105	0.00118	CcSEcCtD
Ibandronate—Erythema—Fluorouracil—skin cancer	0.00104	0.00118	CcSEcCtD
Ibandronate—Angioedema—Temozolomide—skin cancer	0.00104	0.00117	CcSEcCtD
Ibandronate—Malaise—Temozolomide—skin cancer	0.00102	0.00116	CcSEcCtD
Ibandronate—Dizziness—Imiquimod—skin cancer	0.00102	0.00115	CcSEcCtD
Ibandronate—Vertigo—Temozolomide—skin cancer	0.00102	0.00115	CcSEcCtD
Ibandronate—Infection—Dactinomycin—skin cancer	0.00102	0.00115	CcSEcCtD
Ibandronate—Palpitations—Temozolomide—skin cancer	0.001	0.00113	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000999	0.00113	CcSEcCtD
Ibandronate—Paraesthesia—Bleomycin—skin cancer	0.000985	0.00111	CcSEcCtD
Ibandronate—Vomiting—Imiquimod—skin cancer	0.000982	0.00111	CcSEcCtD
Ibandronate—Weight decreased—Docetaxel—skin cancer	0.000979	0.00111	CcSEcCtD
Ibandronate—Hypertension—Temozolomide—skin cancer	0.000979	0.00111	CcSEcCtD
Ibandronate—Rash—Imiquimod—skin cancer	0.000973	0.0011	CcSEcCtD
Ibandronate—Dermatitis—Imiquimod—skin cancer	0.000973	0.0011	CcSEcCtD
Ibandronate—Pneumonia—Docetaxel—skin cancer	0.00097	0.0011	CcSEcCtD
Ibandronate—Headache—Imiquimod—skin cancer	0.000967	0.00109	CcSEcCtD
Ibandronate—Anaemia—Fluorouracil—skin cancer	0.000965	0.00109	CcSEcCtD
Ibandronate—Arthralgia—Temozolomide—skin cancer	0.000965	0.00109	CcSEcCtD
Ibandronate—Myalgia—Temozolomide—skin cancer	0.000965	0.00109	CcSEcCtD
Ibandronate—Infestation NOS—Docetaxel—skin cancer	0.000965	0.00109	CcSEcCtD
Ibandronate—Infestation—Docetaxel—skin cancer	0.000965	0.00109	CcSEcCtD
Ibandronate—Anxiety—Temozolomide—skin cancer	0.000962	0.00109	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000958	0.00108	CcSEcCtD
Ibandronate—Discomfort—Temozolomide—skin cancer	0.000954	0.00108	CcSEcCtD
Ibandronate—Decreased appetite—Bleomycin—skin cancer	0.000953	0.00108	CcSEcCtD
Ibandronate—Renal failure—Docetaxel—skin cancer	0.000948	0.00107	CcSEcCtD
Ibandronate—Dry mouth—Temozolomide—skin cancer	0.000944	0.00107	CcSEcCtD
Ibandronate—Stomatitis—Docetaxel—skin cancer	0.00094	0.00106	CcSEcCtD
Ibandronate—Pain—Bleomycin—skin cancer	0.000938	0.00106	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000932	0.00105	CcSEcCtD
Ibandronate—Anaphylactic shock—Temozolomide—skin cancer	0.000925	0.00105	CcSEcCtD
Ibandronate—Infection—Temozolomide—skin cancer	0.000919	0.00104	CcSEcCtD
Ibandronate—Nausea—Imiquimod—skin cancer	0.000917	0.00104	CcSEcCtD
Ibandronate—Hepatobiliary disease—Docetaxel—skin cancer	0.000912	0.00103	CcSEcCtD
Ibandronate—Nervous system disorder—Temozolomide—skin cancer	0.000907	0.00103	CcSEcCtD
Ibandronate—Feeling abnormal—Bleomycin—skin cancer	0.000904	0.00102	CcSEcCtD
Ibandronate—Skin disorder—Temozolomide—skin cancer	0.000899	0.00102	CcSEcCtD
Ibandronate—Hyperhidrosis—Temozolomide—skin cancer	0.000894	0.00101	CcSEcCtD
Ibandronate—Chest pain—Fluorouracil—skin cancer	0.000889	0.00101	CcSEcCtD
Ibandronate—Myalgia—Fluorouracil—skin cancer	0.000889	0.00101	CcSEcCtD
Ibandronate—Decreased appetite—Dactinomycin—skin cancer	0.000889	0.00101	CcSEcCtD
Ibandronate—Fatigue—Dactinomycin—skin cancer	0.000882	0.000997	CcSEcCtD
Ibandronate—Discomfort—Fluorouracil—skin cancer	0.000879	0.000993	CcSEcCtD
Ibandronate—Pain—Dactinomycin—skin cancer	0.000875	0.000989	CcSEcCtD
Ibandronate—Urticaria—Bleomycin—skin cancer	0.000871	0.000985	CcSEcCtD
Ibandronate—Haemoglobin—Docetaxel—skin cancer	0.00087	0.000984	CcSEcCtD
Ibandronate—Body temperature increased—Bleomycin—skin cancer	0.000867	0.00098	CcSEcCtD
Ibandronate—Haemorrhage—Docetaxel—skin cancer	0.000866	0.000979	CcSEcCtD
Ibandronate—Pharyngitis—Docetaxel—skin cancer	0.00086	0.000972	CcSEcCtD
Ibandronate—Urinary tract disorder—Docetaxel—skin cancer	0.000855	0.000967	CcSEcCtD
Ibandronate—Oedema peripheral—Docetaxel—skin cancer	0.000853	0.000964	CcSEcCtD
Ibandronate—Anaphylactic shock—Fluorouracil—skin cancer	0.000852	0.000964	CcSEcCtD
Ibandronate—Connective tissue disorder—Docetaxel—skin cancer	0.000851	0.000962	CcSEcCtD
Ibandronate—Urethral disorder—Docetaxel—skin cancer	0.000849	0.00096	CcSEcCtD
Ibandronate—Infection—Fluorouracil—skin cancer	0.000847	0.000957	CcSEcCtD
Ibandronate—Feeling abnormal—Dactinomycin—skin cancer	0.000843	0.000953	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000843	0.000953	CcSEcCtD
Ibandronate—Insomnia—Temozolomide—skin cancer	0.000837	0.000946	CcSEcCtD
Ibandronate—Gastrointestinal pain—Dactinomycin—skin cancer	0.000836	0.000945	CcSEcCtD
Ibandronate—Nervous system disorder—Fluorouracil—skin cancer	0.000836	0.000945	CcSEcCtD
Ibandronate—Paraesthesia—Temozolomide—skin cancer	0.000831	0.000939	CcSEcCtD
Ibandronate—Dyspepsia—Temozolomide—skin cancer	0.000814	0.000921	CcSEcCtD
Ibandronate—Eye disorder—Docetaxel—skin cancer	0.000809	0.000915	CcSEcCtD
Ibandronate—Abdominal pain—Dactinomycin—skin cancer	0.000809	0.000914	CcSEcCtD
Ibandronate—Body temperature increased—Dactinomycin—skin cancer	0.000809	0.000914	CcSEcCtD
Ibandronate—Hypersensitivity—Bleomycin—skin cancer	0.000808	0.000913	CcSEcCtD
Ibandronate—Decreased appetite—Temozolomide—skin cancer	0.000804	0.000909	CcSEcCtD
Ibandronate—Cardiac disorder—Docetaxel—skin cancer	0.000804	0.000908	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Temozolomide—skin cancer	0.000799	0.000903	CcSEcCtD
Ibandronate—Fatigue—Temozolomide—skin cancer	0.000798	0.000902	CcSEcCtD
Ibandronate—Pain—Temozolomide—skin cancer	0.000791	0.000894	CcSEcCtD
Ibandronate—Constipation—Temozolomide—skin cancer	0.000791	0.000894	CcSEcCtD
Ibandronate—Asthenia—Bleomycin—skin cancer	0.000787	0.000889	CcSEcCtD
Ibandronate—Angiopathy—Docetaxel—skin cancer	0.000786	0.000888	CcSEcCtD
Ibandronate—Immune system disorder—Docetaxel—skin cancer	0.000782	0.000884	CcSEcCtD
Ibandronate—Mediastinal disorder—Docetaxel—skin cancer	0.000781	0.000882	CcSEcCtD
Ibandronate—Chills—Docetaxel—skin cancer	0.000777	0.000878	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000777	0.000878	CcSEcCtD
Ibandronate—Pruritus—Bleomycin—skin cancer	0.000776	0.000877	CcSEcCtD
Ibandronate—Insomnia—Fluorouracil—skin cancer	0.000771	0.000871	CcSEcCtD
Ibandronate—Paraesthesia—Fluorouracil—skin cancer	0.000765	0.000865	CcSEcCtD
Ibandronate—Alopecia—Docetaxel—skin cancer	0.000765	0.000865	CcSEcCtD
Ibandronate—Feeling abnormal—Temozolomide—skin cancer	0.000762	0.000862	CcSEcCtD
Ibandronate—Mental disorder—Docetaxel—skin cancer	0.000759	0.000858	CcSEcCtD
Ibandronate—Gastrointestinal pain—Temozolomide—skin cancer	0.000757	0.000855	CcSEcCtD
Ibandronate—Malnutrition—Docetaxel—skin cancer	0.000754	0.000852	CcSEcCtD
Ibandronate—Erythema—Docetaxel—skin cancer	0.000754	0.000852	CcSEcCtD
Ibandronate—Hypersensitivity—Dactinomycin—skin cancer	0.000754	0.000852	CcSEcCtD
Ibandronate—Dyspepsia—Fluorouracil—skin cancer	0.00075	0.000848	CcSEcCtD
Ibandronate—Decreased appetite—Fluorouracil—skin cancer	0.000741	0.000838	CcSEcCtD
Ibandronate—Dysgeusia—Docetaxel—skin cancer	0.000738	0.000834	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000736	0.000832	CcSEcCtD
Ibandronate—Urticaria—Temozolomide—skin cancer	0.000735	0.000831	CcSEcCtD
Ibandronate—Asthenia—Dactinomycin—skin cancer	0.000734	0.00083	CcSEcCtD
Ibandronate—Body temperature increased—Temozolomide—skin cancer	0.000731	0.000827	CcSEcCtD
Ibandronate—Abdominal pain—Temozolomide—skin cancer	0.000731	0.000827	CcSEcCtD
Ibandronate—Back pain—Docetaxel—skin cancer	0.000729	0.000824	CcSEcCtD
Ibandronate—Pain—Fluorouracil—skin cancer	0.000729	0.000824	CcSEcCtD
Ibandronate—Muscle spasms—Docetaxel—skin cancer	0.000725	0.000819	CcSEcCtD
Ibandronate—Feeling abnormal—Fluorouracil—skin cancer	0.000702	0.000794	CcSEcCtD
Ibandronate—Diarrhoea—Dactinomycin—skin cancer	0.0007	0.000791	CcSEcCtD
Ibandronate—Vomiting—Bleomycin—skin cancer	0.000697	0.000788	CcSEcCtD
Ibandronate—Anaemia—Docetaxel—skin cancer	0.000697	0.000788	CcSEcCtD
Ibandronate—Rash—Bleomycin—skin cancer	0.000692	0.000782	CcSEcCtD
Ibandronate—Dermatitis—Bleomycin—skin cancer	0.000691	0.000781	CcSEcCtD
Ibandronate—Hypersensitivity—Temozolomide—skin cancer	0.000682	0.00077	CcSEcCtD
Ibandronate—Urticaria—Fluorouracil—skin cancer	0.000677	0.000765	CcSEcCtD
Ibandronate—Body temperature increased—Fluorouracil—skin cancer	0.000674	0.000762	CcSEcCtD
Ibandronate—Palpitations—Docetaxel—skin cancer	0.000666	0.000753	CcSEcCtD
Ibandronate—Asthenia—Temozolomide—skin cancer	0.000664	0.00075	CcSEcCtD
Ibandronate—Pruritus—Temozolomide—skin cancer	0.000655	0.00074	CcSEcCtD
Ibandronate—Nausea—Bleomycin—skin cancer	0.000651	0.000736	CcSEcCtD
Ibandronate—Hypertension—Docetaxel—skin cancer	0.000651	0.000736	CcSEcCtD
Ibandronate—Vomiting—Dactinomycin—skin cancer	0.00065	0.000735	CcSEcCtD
Ibandronate—Rash—Dactinomycin—skin cancer	0.000645	0.000729	CcSEcCtD
Ibandronate—Arthralgia—Docetaxel—skin cancer	0.000642	0.000725	CcSEcCtD
Ibandronate—Myalgia—Docetaxel—skin cancer	0.000642	0.000725	CcSEcCtD
Ibandronate—Chest pain—Docetaxel—skin cancer	0.000642	0.000725	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000637	0.00072	CcSEcCtD
Ibandronate—Diarrhoea—Temozolomide—skin cancer	0.000633	0.000716	CcSEcCtD
Ibandronate—Hypersensitivity—Fluorouracil—skin cancer	0.000628	0.00071	CcSEcCtD
Ibandronate—Dry mouth—Docetaxel—skin cancer	0.000628	0.000709	CcSEcCtD
Ibandronate—Anaphylactic shock—Docetaxel—skin cancer	0.000615	0.000695	CcSEcCtD
Ibandronate—Dizziness—Temozolomide—skin cancer	0.000612	0.000692	CcSEcCtD
Ibandronate—Infection—Docetaxel—skin cancer	0.000611	0.000691	CcSEcCtD
Ibandronate—Nausea—Dactinomycin—skin cancer	0.000608	0.000687	CcSEcCtD
Ibandronate—Shock—Docetaxel—skin cancer	0.000605	0.000684	CcSEcCtD
Ibandronate—Nervous system disorder—Docetaxel—skin cancer	0.000603	0.000682	CcSEcCtD
Ibandronate—Pruritus—Fluorouracil—skin cancer	0.000603	0.000682	CcSEcCtD
Ibandronate—Skin disorder—Docetaxel—skin cancer	0.000598	0.000676	CcSEcCtD
Ibandronate—Vomiting—Temozolomide—skin cancer	0.000588	0.000665	CcSEcCtD
Ibandronate—Rash—Temozolomide—skin cancer	0.000583	0.000659	CcSEcCtD
Ibandronate—Diarrhoea—Fluorouracil—skin cancer	0.000583	0.000659	CcSEcCtD
Ibandronate—Dermatitis—Temozolomide—skin cancer	0.000583	0.000659	CcSEcCtD
Ibandronate—Headache—Temozolomide—skin cancer	0.00058	0.000655	CcSEcCtD
Ibandronate—Dizziness—Fluorouracil—skin cancer	0.000564	0.000637	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000561	0.000634	CcSEcCtD
Ibandronate—Insomnia—Docetaxel—skin cancer	0.000556	0.000629	CcSEcCtD
Ibandronate—Paraesthesia—Docetaxel—skin cancer	0.000552	0.000624	CcSEcCtD
Ibandronate—Nausea—Temozolomide—skin cancer	0.00055	0.000621	CcSEcCtD
Ibandronate—Vomiting—Fluorouracil—skin cancer	0.000542	0.000613	CcSEcCtD
Ibandronate—Dyspepsia—Docetaxel—skin cancer	0.000542	0.000612	CcSEcCtD
Ibandronate—Rash—Fluorouracil—skin cancer	0.000537	0.000608	CcSEcCtD
Ibandronate—Dermatitis—Fluorouracil—skin cancer	0.000537	0.000607	CcSEcCtD
Ibandronate—Decreased appetite—Docetaxel—skin cancer	0.000535	0.000605	CcSEcCtD
Ibandronate—Headache—Fluorouracil—skin cancer	0.000534	0.000604	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Docetaxel—skin cancer	0.000531	0.0006	CcSEcCtD
Ibandronate—Fatigue—Docetaxel—skin cancer	0.00053	0.0006	CcSEcCtD
Ibandronate—Constipation—Docetaxel—skin cancer	0.000526	0.000595	CcSEcCtD
Ibandronate—Pain—Docetaxel—skin cancer	0.000526	0.000595	CcSEcCtD
Ibandronate—Feeling abnormal—Docetaxel—skin cancer	0.000507	0.000573	CcSEcCtD
Ibandronate—Nausea—Fluorouracil—skin cancer	0.000506	0.000572	CcSEcCtD
Ibandronate—Gastrointestinal pain—Docetaxel—skin cancer	0.000503	0.000569	CcSEcCtD
Ibandronate—Body temperature increased—Docetaxel—skin cancer	0.000486	0.00055	CcSEcCtD
Ibandronate—Abdominal pain—Docetaxel—skin cancer	0.000486	0.00055	CcSEcCtD
Ibandronate—Hypersensitivity—Docetaxel—skin cancer	0.000453	0.000512	CcSEcCtD
Ibandronate—Asthenia—Docetaxel—skin cancer	0.000441	0.000499	CcSEcCtD
Ibandronate—Pruritus—Docetaxel—skin cancer	0.000435	0.000492	CcSEcCtD
Ibandronate—Diarrhoea—Docetaxel—skin cancer	0.000421	0.000476	CcSEcCtD
Ibandronate—Dizziness—Docetaxel—skin cancer	0.000407	0.00046	CcSEcCtD
Ibandronate—Vomiting—Docetaxel—skin cancer	0.000391	0.000442	CcSEcCtD
Ibandronate—Rash—Docetaxel—skin cancer	0.000388	0.000438	CcSEcCtD
Ibandronate—Dermatitis—Docetaxel—skin cancer	0.000388	0.000438	CcSEcCtD
Ibandronate—Headache—Docetaxel—skin cancer	0.000385	0.000436	CcSEcCtD
Ibandronate—Nausea—Docetaxel—skin cancer	0.000365	0.000413	CcSEcCtD
